These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36695485)

  • 41. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.
    Lyngse FP; Kirkeby CT; Denwood M; Christiansen LE; Mølbak K; Møller CH; Skov RL; Krause TG; Rasmussen M; Sieber RN; Johannesen TB; Lillebaek T; Fonager J; Fomsgaard A; Møller FT; Stegger M; Overvad M; Spiess K; Mortensen LH
    Nat Commun; 2022 Sep; 13(1):5760. PubMed ID: 36180438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in cerebrovascular disease-related deaths and their location during the COVID-19 pandemic in Japan.
    Nomura S; Eguchi A; Ghaznavi C; Yamasaki L; Rauniyar SK; Tanoue Y; Kawashima T; Yoneoka D; Kohsaka S; Suzuki M; Hashizume M
    Public Health; 2023 May; 218():176-179. PubMed ID: 37060737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark.
    Hansen CH; Friis NU; Bager P; Stegger M; Fonager J; Fomsgaard A; Gram MA; Christiansen LE; Ethelberg S; Legarth R; Krause TG; Ullum H; Valentiner-Branth P
    Lancet Infect Dis; 2023 Feb; 23(2):167-176. PubMed ID: 36270311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.
    Brüssow H
    Microb Biotechnol; 2022 Jul; 15(7):1927-1939. PubMed ID: 35443078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Abdullah F; Myers J; Basu D; Tintinger G; Ueckermann V; Mathebula M; Ramlall R; Spoor S; de Villiers T; Van der Walt Z; Cloete J; Soma-Pillay P; Rheeder P; Paruk F; Engelbrecht A; Lalloo V; Myburg M; Kistan J; van Hougenhouck-Tulleken W; Boswell MT; Gray G; Welch R; Blumberg L; Jassat W
    Int J Infect Dis; 2022 Mar; 116():38-42. PubMed ID: 34971823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
    Postill G; Murray R; Wilton AS; Wells RA; Sirbu R; Daley MJ; Rosella L
    JMIR Public Health Surveill; 2022 Feb; 8(2):e32426. PubMed ID: 35038302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
    Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid Estimation of Excess Mortality during the COVID-19 Pandemic in Portugal -Beyond Reported Deaths.
    Vieira A; Peixoto VR; Aguiar P; Abrantes A
    J Epidemiol Glob Health; 2020 Sep; 10(3):209-213. PubMed ID: 32954711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance.
    Odone A; Delmonte D; Gaetti G; Signorelli C
    Public Health; 2021 Jan; 190():108-115. PubMed ID: 33412438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.
    Domínguez-Ramírez L; Solis-Tejeda I; Ayon-Aguilar J; Mayoral-Ortiz A; Sosa-Jurado F; Pelayo R; Santos-López G; Cortes-Hernandez P
    Front Public Health; 2022; 10():1010256. PubMed ID: 36176536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020.
    Lyngse FP; Kirkeby C; Halasa T; Andreasen V; Skov RL; Møller FT; Krause TG; Mølbak K
    Euro Surveill; 2022 Feb; 27(6):. PubMed ID: 35144726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries.
    Chen B; Zhao Y; Jin Z; He D; Li H
    BMC Infect Dis; 2023 Jan; 23(1):25. PubMed ID: 36639649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.